German Experience With Bendamustine Treating Relapsed/Refractory Indolent B-Cell and Mantle Cell Lymphomas
To access this article, please choose from the options below
PII: S0037-1963(07)00094-7
doi:10.1053/j.seminhematol.2007.06.003
© 2007 Elsevier Inc. All rights reserved.
